Application

17916230 · CD38 INHIBITORS

Filed 2022-09-30 · Granted · Patent 12514858 (2026-01-06) The official file ↗The patent and its PDF ↗ · Art unit 1619 · Examiner David J Blanchard Typical · CPC A61K 31/506 · Astellas Engineered Small Molecules US, Incorporated · MCCARTER & ENGLISH, LLP BOSTON

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

31.4 mo

to disposition 39.2 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.